Phase II Clinical Trial: Ex Vivo Drug Sensitivity Testing in Parallel with Physician Selected Selinexor-Based Therapy for Multiple Myeloma

Zachary J. Walker, Daniel W. Sherbenou, Lauren T. Reiman et al.|Blood|2024

Cited by 1